STRATA Skin Sciences, Inc. (SSKN)
USD 2.62
(-0.76%)
USD 2.62
(-0.76%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -8.6 Million USD | -38.6% |
| 2022 | -4.56 Million USD | -3.59% |
| 2021 | -4.4 Million USD | -8.0% |
| 2020 | -4.07 Million USD | -57.01% |
| 2019 | -2.59 Million USD | 22.62% |
| 2018 | -3.35 Million USD | -39.21% |
| 2017 | -2.41 Million USD | 33.0% |
| 2016 | -3.59 Million USD | 78.17% |
| 2015 | -16.47 Million USD | 0.88% |
| 2014 | -16.62 Million USD | 31.13% |
| 2013 | -24.13 Million USD | -6.2% |
| 2012 | -22.72 Million USD | -11.06% |
| 2011 | -20.46 Million USD | -1.12% |
| 2010 | -20.23 Million USD | -8.9% |
| 2009 | -18.58 Million USD | -1.68% |
| 2008 | -18.27 Million USD | -39.73% |
| 2007 | -13.07 Million USD | -8.08% |
| 2006 | -12.1 Million USD | -87.38% |
| 2005 | -6.45 Million USD | -106.6% |
| 2004 | -3.12 Million USD | -67.87% |
| 2003 | -1.86 Million USD | -103.5% |
| 2002 | -915 Thousand USD | 66.2% |
| 2001 | -2.7 Million USD | -48.33% |
| 2000 | -1.82 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -2.87 Million USD | -148.57% |
| 2024 Q2 | -480 Thousand USD | 83.1% |
| 2023 FY | -6.32 Million USD | -38.6% |
| 2023 Q1 | -2.58 Million USD | -2029.85% |
| 2023 Q3 | -615 Thousand USD | 68.65% |
| 2023 Q4 | -1.15 Million USD | -88.13% |
| 2023 Q2 | -1.96 Million USD | 24.13% |
| 2022 Q1 | -2.3 Million USD | 22.87% |
| 2022 FY | -4.56 Million USD | -3.59% |
| 2022 Q4 | 134 Thousand USD | 117.84% |
| 2022 Q3 | -751 Thousand USD | 55.67% |
| 2022 Q2 | -1.69 Million USD | 26.44% |
| 2021 Q3 | -465 Thousand USD | 49.62% |
| 2021 Q2 | -923 Thousand USD | 61.41% |
| 2021 Q1 | -2.39 Million USD | -579.55% |
| 2021 FY | -4.4 Million USD | -8.0% |
| 2021 Q4 | -2.98 Million USD | -542.15% |
| 2020 Q2 | -1.61 Million USD | -70.36% |
| 2020 Q1 | -948 Thousand USD | -1563.16% |
| 2020 Q3 | -1.16 Million USD | 28.11% |
| 2020 FY | -4.07 Million USD | -57.01% |
| 2020 Q4 | -352 Thousand USD | 69.68% |
| 2019 Q2 | -983 Thousand USD | 20.79% |
| 2019 Q4 | -57 Thousand USD | 92.18% |
| 2019 Q1 | -1.24 Million USD | -139.58% |
| 2019 Q3 | -729 Thousand USD | 25.84% |
| 2019 FY | -2.59 Million USD | 22.62% |
| 2018 Q4 | -518 Thousand USD | -896.15% |
| 2018 Q2 | -946 Thousand USD | 48.61% |
| 2018 Q1 | -1.84 Million USD | -26.1% |
| 2018 FY | -3.35 Million USD | -39.21% |
| 2018 Q3 | -52 Thousand USD | 94.5% |
| 2017 Q3 | -572 Thousand USD | -285.11% |
| 2017 Q2 | 309 Thousand USD | 144.98% |
| 2017 Q1 | -687 Thousand USD | -270.05% |
| 2017 FY | -2.41 Million USD | 33.0% |
| 2017 Q4 | -1.46 Million USD | -155.24% |
| 2016 Q1 | -2.13 Million USD | -41.12% |
| 2016 Q4 | 404 Thousand USD | 199.75% |
| 2016 Q3 | -405 Thousand USD | 72.22% |
| 2016 FY | -3.59 Million USD | 78.17% |
| 2016 Q2 | -1.45 Million USD | 31.81% |
| 2015 Q4 | -1.51 Million USD | 34.78% |
| 2015 Q1 | -3.63 Million USD | -0.02% |
| 2015 FY | -16.47 Million USD | 0.88% |
| 2015 Q3 | -2.32 Million USD | 74.2% |
| 2015 Q2 | -9 Million USD | -147.97% |
| 2014 Q4 | -3.63 Million USD | 9.25% |
| 2014 FY | -16.62 Million USD | 31.13% |
| 2014 Q3 | -4 Million USD | 6.04% |
| 2014 Q2 | -4.25 Million USD | 10.02% |
| 2014 Q1 | -4.73 Million USD | -7.31% |
| 2013 Q1 | -6.48 Million USD | -6.54% |
| 2013 FY | -24.13 Million USD | -6.2% |
| 2013 Q4 | -4.4 Million USD | 28.95% |
| 2013 Q3 | -6.2 Million USD | 11.75% |
| 2013 Q2 | -7.03 Million USD | -8.44% |
| 2012 Q1 | -5.77 Million USD | -27.22% |
| 2012 FY | -22.72 Million USD | -11.06% |
| 2012 Q4 | -6.08 Million USD | -13.4% |
| 2012 Q3 | -5.36 Million USD | 2.37% |
| 2012 Q2 | -5.49 Million USD | 4.73% |
| 2011 FY | -20.46 Million USD | -1.12% |
| 2011 Q1 | -4.96 Million USD | 11.36% |
| 2011 Q4 | -4.53 Million USD | 25.97% |
| 2011 Q3 | -6.12 Million USD | -26.91% |
| 2011 Q2 | -4.82 Million USD | 2.83% |
| 2010 Q4 | -5.6 Million USD | -12.8% |
| 2010 Q1 | -5.05 Million USD | 9.42% |
| 2010 FY | -20.23 Million USD | -8.9% |
| 2010 Q2 | -4.6 Million USD | 9.04% |
| 2010 Q3 | -4.96 Million USD | -8.02% |
| 2009 Q4 | -5.58 Million USD | -10.27% |
| 2009 Q2 | -3.87 Million USD | 4.65% |
| 2009 Q1 | -4.06 Million USD | 6.04% |
| 2009 FY | -18.58 Million USD | -1.68% |
| 2009 Q3 | -5.06 Million USD | -30.77% |
| 2008 Q4 | -4.32 Million USD | 1.05% |
| 2008 Q3 | -4.36 Million USD | 14.33% |
| 2008 Q2 | -5.09 Million USD | -13.69% |
| 2008 Q1 | -4.48 Million USD | -29.63% |
| 2008 FY | -18.27 Million USD | -39.73% |
| 2007 Q4 | -3.45 Million USD | -14.22% |
| 2007 Q2 | -3.32 Million USD | -1.85% |
| 2007 FY | -13.07 Million USD | -8.08% |
| 2007 Q3 | -3.02 Million USD | 8.9% |
| 2007 Q1 | -3.26 Million USD | 2.66% |
| 2006 Q1 | -3.06 Million USD | -20.45% |
| 2006 Q2 | -3.01 Million USD | 1.91% |
| 2006 Q3 | -2.57 Million USD | 14.4% |
| 2006 Q4 | -3.35 Million USD | -30.15% |
| 2006 FY | -12.1 Million USD | -87.38% |
| 2005 Q2 | -1.27 Million USD | -11.48% |
| 2005 Q4 | -2.54 Million USD | -86.22% |
| 2005 Q3 | -1.36 Million USD | -7.66% |
| 2005 FY | -6.45 Million USD | -106.6% |
| 2005 Q1 | -1.14 Million USD | 2.36% |
| 2004 Q3 | -626.07 Thousand USD | 0.0% |
| 2004 Q4 | -1.16 Million USD | -86.49% |
| 2004 FY | -3.12 Million USD | -67.87% |
| 2003 FY | -1.86 Million USD | -103.5% |
| 2002 FY | -915 Thousand USD | 66.2% |
| 2001 FY | -2.7 Million USD | -48.33% |
| 2000 FY | -1.82 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 40.088% |
| Cerus Corporation | -30.05 Million USD | 71.371% |
| OrthoPediatrics Corp. | -25.76 Million USD | 66.607% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 18.993% |
| Talis Biomedical Corporation | -66.81 Million USD | 87.123% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 50.254% |
| Inogen, Inc. | -109.38 Million USD | 92.134% |
| Spectral AI, Inc. | -12.98 Million USD | 33.734% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 86.253% |
| CVRx, Inc. | -43.1 Million USD | 80.039% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -143.878% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 30.769% |
| Orthofix Medical Inc. | -139.11 Million USD | 93.815% |
| Venus Concept Inc. | -28.3 Million USD | 69.607% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 84.075% |
| Bioventus Inc. | -81.72 Million USD | 89.472% |
| BrainsWay Ltd. | -4.92 Million USD | -74.63% |
| Envoy Medical, Inc. | -18.37 Million USD | 53.165% |
| electroCore, Inc. | -18.8 Million USD | 54.246% |
| IceCure Medical Ltd | -15.57 Million USD | 44.761% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 82.253% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 50.174% |
| MaxCyte, Inc. | -48.29 Million USD | 82.186% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 28.032% |
| Nexalin Technology, Inc. | -5.69 Million USD | -51.046% |
| PAVmed Inc | -68.79 Million USD | 87.493% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 84.789% |
| RxSight, Inc. | -50.08 Million USD | 82.821% |
| Sight Sciences, Inc. | -57.27 Million USD | 84.977% |
| SI-BONE, Inc. | -46.93 Million USD | 81.667% |
| TELA Bio, Inc. | -44.07 Million USD | 80.479% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 84.111% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 83.27% |
| LivaNova PLC | -68.49 Million USD | 87.439% |
| 908 Devices Inc. | -42.75 Million USD | 79.877% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 95.038% |
| Nemaura Medical Inc. | -9.59 Million USD | 10.33% |
| NeuroPace, Inc. | -27.17 Million USD | 68.337% |
| LENSAR, Inc. | -12.22 Million USD | 29.643% |
| Apyx Medical Corporation | -17.25 Million USD | 50.148% |
| Cutera, Inc. | -156.23 Million USD | 94.493% |
| BioSig Technologies, Inc. | -28.51 Million USD | 69.823% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 90.182% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 61.668% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 107.715% |
| Axonics, Inc. | -26.05 Million USD | 66.98% |
| Outset Medical, Inc. | -169.77 Million USD | 94.932% |
| IRIDEX Corporation | -10 Million USD | 14.02% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 92.119% |
| IRadimed Corporation | 20.03 Million USD | 142.944% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -4.354% |
| INVO Bioscience, Inc. | -6.76 Million USD | -27.144% |
| Telesis Bio, Inc. | -35.15 Million USD | 75.522% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 160.042% |
| Varex Imaging Corporation | 32.1 Million USD | 126.804% |
| Quipt Home Medical Corp. | 3.91 Million USD | 319.546% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 29.086% |
| Pulmonx Corporation | -61.93 Million USD | 86.108% |
| Dynatronics Corporation | -2.27 Million USD | -278.523% |
| Modular Medical, Inc. | -17.52 Million USD | 50.916% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 41.225% |
| Semler Scientific, Inc. | 22.25 Million USD | 138.659% |
| InMode Ltd. | 195.66 Million USD | 104.397% |
| Bruker Corporation | 436.9 Million USD | 101.969% |
| Cytosorbents Corporation | -31.2 Million USD | 72.431% |
| DexCom, Inc. | 597.7 Million USD | 101.44% |
| Align Technology, Inc. | 643.33 Million USD | 101.337% |
| Viveve Medical, Inc. | -21.55 Million USD | 60.08% |
| ZimVie Inc. | -30.93 Million USD | 72.19% |
| Movano Inc. | -29.69 Million USD | 71.021% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 69.1% |
| Nexalin Technology, Inc. | -5.69 Million USD | -51.046% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -143.878% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 96.311% |
| Profound Medical Corp. | -28.61 Million USD | 69.933% |
| Insulet Corporation | 220 Million USD | 103.911% |
| enVVeno Medical Corporation | -25.23 Million USD | 65.909% |
| Surmodics, Inc. | -5.64 Million USD | -52.418% |
| iCAD, Inc. | -7.68 Million USD | -11.9% |
| Nuwellis, Inc. | -17.63 Million USD | 51.197% |
| Biotricity, Inc. | -8.82 Million USD | 2.54% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 93.126% |
| Aethlon Medical, Inc. | -12.63 Million USD | 31.912% |
| InspireMD, Inc. | -21.14 Million USD | 59.306% |
| PAVmed Inc. | -68.79 Million USD | 87.493% |
| BIOLASE, Inc. | -17.93 Million USD | 52.032% |
| Beyond Air, Inc. | -63 Million USD | 86.344% |
| FONAR Corporation | 16.53 Million USD | 152.034% |
| AxoGen, Inc. | -21.46 Million USD | 59.911% |
| Vivani Medical, Inc. | -26.96 Million USD | 68.092% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 147.691% |
| Inari Medical, Inc. | -14.03 Million USD | 38.683% |
| UFP Technologies, Inc. | 57.66 Million USD | 114.921% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -74.608% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -36.446% |
| Tenon Medical, Inc. | -15.72 Million USD | 45.292% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -15.119% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 79.853% |
| AdaptHealth Corp. | -598.4 Million USD | 98.562% |
| Sintx Technologies, Inc. | -13.35 Million USD | 35.589% |
| NanoVibronix, Inc. | -3.43 Million USD | -150.407% |
| Quanterix Corporation | -49.7 Million USD | 82.688% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 29.086% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -2152.356% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 97.428% |
| TransMedics Group, Inc. | -28.72 Million USD | 70.049% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 63.561% |
| NeuroMetrix, Inc. | -7.15 Million USD | -20.31% |
| Hyperfine, Inc. | -48.11 Million USD | 82.118% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 86.768% |
| Biomerica, Inc. | -6.36 Million USD | -35.134% |
| Bone Biologics Corporation | -9.42 Million USD | 8.743% |
| AVITA Medical, Inc. | -40.4 Million USD | 78.704% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 16.557% |
| Silk Road Medical, Inc | -59.27 Million USD | 85.484% |